The Need for the Optimization of HIV Antiretroviral Therapy in Kazakhstan. [PDF]
Mustafa A+5 more
europepmc +1 more source
Influence of antiretroviral therapy on frailty among people living with HIV. [PDF]
Contreras Macías E+2 more
europepmc +1 more source
Salvage therapy with an Albuvirtide-based antiretroviral regimen for multi-drug resistant HIV and drug-resistant HBV with renal impairment: a case report. [PDF]
He Y, Liao B, Liu Y, Cao Y, Li L, Cai W.
europepmc +1 more source
Microwave-assisted synthesis of a zirconium-based MOF as an efficient catalyst for one-pot synthesis of xanthene derivatives: <i>in silico</i> study as a potential anti-HIV RNA. [PDF]
Alsalhi MS+5 more
europepmc +1 more source
HIV-1 prevalence, drug resistance, and associated factors in the urban Ethiopian population. [PDF]
Deress T, Worede A, Birhanu A, Girma M.
europepmc +1 more source
Prevalence of drug resistance mutations in low-level viremia patients under antiretroviral therapy in Southwestern China: a cross-sectional study. [PDF]
Shu Y+7 more
europepmc +1 more source
A Stable Switch From Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/FTC/TAF) to Dolutegravir/Lamivudine (DTG/3TC) in the Absence of Historical Resistance Records: Results From the Switch to Dovato in Patients Suppressed on Biktarvy (SOUND) Cohort. [PDF]
Slim J+4 more
europepmc +1 more source
HIV-1 suppression and rare dolutegravir resistance in antiretroviral-experienced people with HIV in Liberia. [PDF]
Moses JS+29 more
europepmc +1 more source
High concordance of human immunodeficiency virus-1 genotypic drug resistance generated from paired cerebrospinal fluid and plasma in antiretroviral therapy -naive or -experienced patients. [PDF]
Deng X+9 more
europepmc +1 more source